Several companies announced expansion plans with billion-dollar commitments to increase local production in key sectors such as technology, automotive, and healthcare.
As the trade policies of the Donald Trump administration continue to shape the U.S. economic landscape, several major companies have recently announced plans to expand their manufacturing capabilities in the country.
These announcements come amid the implementation of new tariffs on imported products and at a time when other tariffs are still pending.
While not all companies explicitly mention these tariffs as a motivating factor, the White House has seized the opportunity to highlight these investments as part of its strategy to boost job creation and manufacturing on U.S. soil.
In March of this year, the White House celebrated the $55 billion investment announced by Johnson & Johnson to expand its manufacturing in the United States, calling it a “massive victory” in Trump’s effort to achieve U.S. manufacturing supremacy. However, trade and economic experts are more skeptical about whether tariffs will be the primary lever for companies to change their investment decisions.
Factors such as labor costs, taxes, political stability, and the overall regulatory environment are typically more important determinants when deciding where to establish new production plants, according to economists.
Despite the criticism, many analysts agree that tariffs, particularly those applied to products that are not key components of other goods, can help stimulate local production in certain sectors by making imported products more expensive compared to domestic ones.
In this context, tariffs could be a useful tool to protect and promote emerging industries, but there are also risks associated with a broader trade policy that affects a wide range of products and could generate adverse effects on employment and costs globally, according to a CBS News analysis.
Abbott Laboratories
A clear example of how some companies are responding to these incentives is Abbott Laboratories, the Illinois-based medical device giant. The company recently announced it will invest $500 million to expand its plants in Illinois and Texas, resulting in the creation of up to 300 new jobs.
Abbott already has production plants in several countries, and its expansion in the United States aims to strengthen its local production capacity and secure the supply of key medical devices, a sector where trade tensions can have significant implications.
Apple
For its part, Apple has announced an unprecedented $500 billion investment to expand its manufacturing in the United States over the next four years. This is Apple’s largest investment in U.S. soil, reaffirming its confidence in the future of technological innovation in the country.
In its plan, Apple will expand existing facilities and build a new plant in Houston, Texas, dedicated to manufacturing servers for its artificial intelligence (AI), an area in which the company is heavily investing.
The investment includes job creation in Arizona, California, Iowa, Michigan, Nevada, North Carolina, Oregon, Texas, and Washington. Tim Cook, Apple’s CEO, stated in a press release that the company is “optimistic about the future of American innovation” and highlighted the importance of its Advanced Manufacturing Fund, through which Apple aims to drive the development of advanced technologies within the United States.
Chobani
Another relevant case is Chobani, the well-known Greek yogurt brand. The company announced it will invest at least $1.2 billion in building a plant in Rome, New York, which will have an annual production capacity of up to 453,600 tons of dairy products.
According to its executives, this new plant will be the largest dairy production facility in the United States and will generate 1,000 new jobs in the region. Chobani’s expansion follows another major investment in Twin Falls, Idaho, where the company had already committed $500 million in March.
Cra-Z-Art
In a different but equally relevant sector, Cra-Z-Art, a New Jersey-based toy manufacturer, has taken steps to increase its production in the United States. In March, the company announced it would expand its manufacturing capacity by 50% to counteract the effects of tariffs imposed on products imported from China and other countries.
Johnson and Johnson
In March, Johnson & Johnson also highlighted its commitment to U.S. manufacturing by announcing a $55 billion investment to build new facilities in the country. One of the first initiatives will be the creation of a plant in Wilson, North Carolina, which will focus on manufacturing cutting-edge drugs to treat cancer and neurological and immunological diseases.
Honda and Hyundai
In the automotive sector, Honda Motor has announced it will move production of its Civic Hybrid Hatchback from Japan to Indiana due to the 25% tariffs imposed on imported vehicles and auto parts. Honda, which currently produces the Civic Hybrid in plants in Indiana and Japan, will begin manufacturing this model exclusively in the United States starting this year.
Meanwhile, Hyundai Motor has committed $21 billion in manufacturing investments in the United States between 2025 and 2028. The South Korean company plans to increase its vehicle production capacity to 1.2 million units annually, which will strengthen its presence in the U.S. market and generate more jobs in the country.
Nvidia and TSMC
Finally, Nvidia, one of the leading U.S. companies in AI chips and supercomputers, announced that for the first time in its history, it will manufacture its chips and supercomputers in the United States. With plans to produce in Arizona and Texas, Nvidia expects to build up to $500 billion in AI infrastructure on U.S. soil.
On the other hand, TSMC, the Taiwanese semiconductor giant, announced a total investment of $165 billion to expand its manufacturing operations in the U.S., including the construction of new plants in Phoenix, Arizona, and the establishment of advanced research and development centers.
